Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-01 Sale |
2023-02-01 9:41 pm |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director |
8,448 | $0.25 | $2,112 | 66,082 (Direct) |
View |
| 2023-01-31 Sale |
2023-01-31 9:51 pm |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director |
7,240 | $0.241 | $1,745 | 192,030 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-01 9:20 pm |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
6,730 | $6.573 | $44,236 | 564,270 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-17 Option Award |
2025-01-22 4:07 pm |
N/A 2035-01-16 |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
40,289 | $0 | 40,289 (Direct) |
View |
| 2024-07-15 Tax Withholding |
2024-07-17 12:28 pm |
N/A N/A |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
749 | $64.25 | 265,581 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 12:28 pm |
N/A 2034-07-14 |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
64,262 | $0 | 265,581 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 1:04 pm |
N/A 2034-01-17 |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
21,843 | $0 | 21,843 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:00 pm |
N/A 2033-07-13 |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
29,943 | $0 | 222,343 (Direct) |
View |
| 2023-06-05 Option Award(A) |
2023-06-21 4:00 pm |
N/A N/A |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
192,400 | $0 | 192,400 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-14 5:05 pm |
N/A 2033-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-05 Option Award |
2023-06-07 2:00 pm |
N/A N/A |
INCYTE CORP | INCY | CAGNONI PABLO J President, R&D |
179,613 | $0 | 179,613 (Direct) |
View |
| 2023-01-29 Exercise |
2023-01-31 9:51 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director |
46,250 | $0 | 192,030 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:05 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-04-26 Ownership |
2022-02-14 7:52 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
6,200 | $0 | 29,320 (Direct) |
View |
| 2022-01-29 Exercise |
2022-02-01 9:20 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
21,250 | $0 | 564,270 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 9:20 pm |
N/A 2032-01-30 |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
465,000 | $0 | 564,270 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:13 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 8:26 pm |
N/A 2031-01-28 |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
460,000 | $0 | 460,000 (Direct) |
View |
Ownership |
2020-10-15 5:02 pm |
N/A N/A |
TURMERIC ACQUISITION CORP. | TMPM | CAGNONI PABLO J Director |
0 | $0 | 25,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 06:36 am |
N/A 2030-06-18 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-06-25 8:00 pm |
N/A 2029-12-01 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
0 | $0 | 141,011 (Direct) |
View |